“All for marketing, all for service marketing”. On the eighth day of the lunar new year, Zhejiang Cheng Yi Pharmaceutical Co.Ltd(603811) held a one-day “closed door meeting” to study how to achieve a “good start” after the Spring Festival: held a symposium for middle and senior managers in the morning to listen to opinions and suggestions on improving the competitiveness of enterprises; In the afternoon, a marketing work symposium was held to convene the product line managers of the marketing center and the managers of the sales departments of various provinces and regions, listen to the sales report of the first quarter, deploy the “good start” battle plan of the whole year, and sound the marching signal of performance to a new level.
Since 2021, Zhejiang Cheng Yi Pharmaceutical Co.Ltd(603811) has focused on R & D of new drugs, strengthening investment, technological transformation, promoting M & A and chain extension, so as to pave the way for a new level of performance in the new year: in terms of R & D, the company has focused on building an “innovation Highland” of marine biomedicine. At present, more than 20 new products are under research, Among them, glucosamine hydrochloride capsule, which is used to treat bone and joint, has achieved the largest sales volume in China; In terms of technological transformation, the company is embarking on the 1000 ton super fish oil EPA project, focusing on building a “digital highland” of pharmaceutical intelligent manufacturing, and has been rated as a pilot demonstration enterprise for the integrated development of new generation information technology and manufacturing industry in Zhejiang Province; In terms of M & A, in 2021, the company acquired three enterprises in Guangzhou and Yunnan to expand the food and health products industry. Up to now, Zhejiang Cheng Yi Pharmaceutical Co.Ltd(603811) has six subsidiaries, forming seven sections including pharmaceutical preparations, APIs, marine medicine, biomedicine, traditional Chinese medicine, medical devices and big health industry. It has become a leading enterprise in Wenzhou’s life and health industry and created a “development highland” of life and health industry.
In 2021, the sales of weiergu glucosamine hydrochloride capsule for the treatment of bone and joint continued the style of winning the first bid in the national collection, with the sales volume leading in the country. At the end of last year, it also obtained the NPN certificate that can enter the Canadian market. Liquan torasemide injection took the lead in passing the national consistency evaluation. The new product ornithine aspartate has been approved by the state for eight years. The production conditions of super fish oil EPA project have been met, laying a good foundation for sustainable sales.
At the marketing symposium, the company commended Yu Haidao, the manager of Yunnan Province, Wang Yong, the manager of Shandong Province, Cai Jianguo, the manager of Henan Province, and Ji dengpan, the manager of Hunan Province
“Provincial sales award and Development Award”. Provincial and regional managers have said that they want to make a good start in the first quarter. In response to the relevant questions raised by everyone, the general manager and chairman studied on the spot and gave satisfactory answers.
Zhao Chunjian, general manager of the company, pointed out during the discussion with all marketing “generals” that at the beginning of the year, the company had formulated the production and operation tasks for 2022 and made decomposition and implementation. Managers of all product lines should go deep into the front line of the market, collect information, take measures and launch policies at the first time, and strive to overcome the adverse effects of the epidemic, Make every effort to ensure the continued growth of revenue and net profit; We should give full play to the fighting spirit of the Corps, fight hard for the first quarter and ensure a good start.
Yan Yiyi, chairman of the company, thanked all the cadres of the marketing center for their hard work for the company’s performance growth and delivering satisfactory answers to the society over the past year. He asked that the marketing tasks in the first quarter should be exceeded. Therefore, we should establish confidence, polish our eyes, pay attention to details and improve the combat effectiveness of the marketing team. The company should establish the concept of “everything serves marketing” and strive to achieve “a good start and a good year” in 2022.
